CD160 (CD160 molecule)

2007-02-01  

Identity

HGNC
LOCATION
1q21.1
LOCUSID
ALIAS
BY55,NK1,NK28

Other Information

Locus ID:

NCBI: 11126
MIM: 604463
HGNC: 17013
Ensembl: ENSG00000117281

Variants:

dbSNP: 11126
ClinVar: 11126
TCGA: ENSG00000117281
COSMIC: CD160

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000117281ENST00000235933O95971
ENSG00000117281ENST00000235933Q6FH89
ENSG00000117281ENST00000369288O95971
ENSG00000117281ENST00000369288Q6FH89
ENSG00000117281ENST00000401557O95971
ENSG00000117281ENST00000584442O95971
ENSG00000117281ENST00000616463O95971

Expression (GTEx)

0
1
2
3
4
5

Pathways

PathwaySourceExternal ID
Immune SystemREACTOMER-HSA-168256
Adaptive Immune SystemREACTOMER-HSA-1280218
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cellREACTOMER-HSA-198933

References

Pubmed IDYearTitleCitations
370141832023Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer.2
370141832023Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer.2
354289102022The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma.6
361108642022CD160 Promotes NK Cell Functions by Upregulating Glucose Metabolism and Negatively Correlates With HIV Disease Progression.9
361636242022[Expression of CD160 in natural killer (NK) cells from patients with active tuberculosis and its relationship with cell functions].0
354289102022The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma.6
361108642022CD160 Promotes NK Cell Functions by Upregulating Glucose Metabolism and Negatively Correlates With HIV Disease Progression.9
361636242022[Expression of CD160 in natural killer (NK) cells from patients with active tuberculosis and its relationship with cell functions].0
339314712021Expanded antigen-experienced CD160(+)CD8(+)effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia.21
342382772021Associations between CD160 polymorphisms and autoimmune thyroid disease: a case-control study.5
342736602021CD160 protein as a new therapeutic target in a battle against autoimmune, infectious and lifestyle diseases. Analysis of the structure, interactions and functions.7
347093512021HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160.10
339314712021Expanded antigen-experienced CD160(+)CD8(+)effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia.21
342382772021Associations between CD160 polymorphisms and autoimmune thyroid disease: a case-control study.5
342736602021CD160 protein as a new therapeutic target in a battle against autoimmune, infectious and lifestyle diseases. Analysis of the structure, interactions and functions.7

Citation

Dessen P

CD160 (CD160 molecule)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/45911/cd160